A Prospective, Randomized, Clinical Trial To Compare Quadrivalent Recombinant Influenza Vaccine (Riv) Versus Quadrivalent Inactivated Influenza Vaccine (IIv) In Pregnant Women
Posted Date: Sep 3, 2019
- Investigator: Emily Defranco
- Specialties:
- Type of Study: Drug
Study participants will be randomized to receive one of two commercially available flu vaccines, which are both currently FDA-approved and recommended for use in pregnant women. The primary aim of the study is to compare proportions of adverse birth outcomes in pregnant women vaccinated with RIV versus IIV, and also compare maternal immune responses to the two vaccines.
Criteria:
Less Than Or Equal To 34 Weeks Of Pregnancy, Plan To Receive Flu Vaccine In Pregnancy
Keywords:
Flu, Pregnancy, Vaccine
For More Information:
Kendall Lombard
513-584-8218
researchob@uchealth.com